Jiajing Lu

870 total citations
61 papers, 533 citations indexed

About

Jiajing Lu is a scholar working on Immunology, Dermatology and Molecular Biology. According to data from OpenAlex, Jiajing Lu has authored 61 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Immunology, 19 papers in Dermatology and 10 papers in Molecular Biology. Recurrent topics in Jiajing Lu's work include Psoriasis: Treatment and Pathogenesis (34 papers), Dermatology and Skin Diseases (18 papers) and Allergic Rhinitis and Sensitization (4 papers). Jiajing Lu is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (34 papers), Dermatology and Skin Diseases (18 papers) and Allergic Rhinitis and Sensitization (4 papers). Jiajing Lu collaborates with scholars based in China, Hong Kong and United States. Jiajing Lu's co-authors include C.N. Coon, John P. McMurtry, Yuling Shi, Yangfeng Ding, Ying Li, Ning Yu, Dawei Huang, Yangfeng Ding, Yanqi Yang and Alice Chin and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Frontiers in Immunology and Journal of Investigative Dermatology.

In The Last Decade

Jiajing Lu

51 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiajing Lu China 12 215 131 115 63 53 61 533
Gui Yang China 17 355 1.7× 248 1.9× 72 0.6× 273 4.3× 18 0.3× 74 930
Aouatef Ismail Chouchane Qatar 8 98 0.5× 107 0.8× 99 0.9× 45 0.7× 199 3.8× 11 478
E. Schauer Austria 5 209 1.0× 87 0.7× 160 1.4× 77 1.2× 25 0.5× 6 687
Caterina Curato Germany 16 307 1.4× 329 2.5× 46 0.4× 68 1.1× 39 0.7× 24 828
Diána Simon Hungary 15 185 0.9× 85 0.6× 35 0.3× 27 0.4× 145 2.7× 44 528
László Pàlinkàs Hungary 13 243 1.1× 115 0.9× 22 0.2× 44 0.7× 44 0.8× 25 573
Katri Niemi Finland 6 151 0.7× 325 2.5× 15 0.1× 48 0.8× 34 0.6× 7 561
Yoon Sook Lee South Korea 16 328 1.5× 122 0.9× 13 0.1× 62 1.0× 25 0.5× 63 791
Mylène Vivinus-Nébot France 7 101 0.5× 167 1.3× 100 0.9× 108 1.7× 29 0.5× 10 673
Shiyuan Huang China 16 242 1.1× 202 1.5× 44 0.4× 194 3.1× 61 1.2× 39 761

Countries citing papers authored by Jiajing Lu

Since Specialization
Citations

This map shows the geographic impact of Jiajing Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiajing Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiajing Lu more than expected).

Fields of papers citing papers by Jiajing Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiajing Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiajing Lu. The network helps show where Jiajing Lu may publish in the future.

Co-authorship network of co-authors of Jiajing Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiajing Lu. A scholar is included among the top collaborators of Jiajing Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiajing Lu. Jiajing Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Rong, Tao Zhou, Jiajing Lu, et al.. (2025). METTL5 Promotes Tumor Progression in Oral Squamous Cell Carcinoma by Activating the Myc Pathway. Journal of Oral Pathology and Medicine. 54(2). 91–99.
2.
Meng, Minghui, Xin Wu, Ting Qin, et al.. (2025). Shp2 regulates the trophoblast cell cycle progression through p53-p21 pathway modulation. Biochemical and Biophysical Research Communications. 776. 152209–152209.
3.
4.
5.
Lu, Jiajing, et al.. (2024). Active Heme Metabolism Suppresses Macrophage Phagocytosis via the TLR4/Type I IFN Signaling/CD36 in Uterine Endometrial Cancer. American Journal of Reproductive Immunology. 92(2). e13916–e13916. 2 indexed citations
6.
Lu, Jiajing, et al.. (2024). Heme metabolism and HO‐1 in the pathogenesis and potential intervention of endometriosis. American Journal of Reproductive Immunology. 91(5). e13855–e13855. 4 indexed citations
7.
Huang, Dawei, Zitong Chen, Yingyuan Yu, et al.. (2024). Advantages of ultrasound imaging for the early diagnosis of psoriatic arthritis in patients with moderate to severe psoriasis. Heliyon. 10(13). e34136–e34136.
8.
Zhang, Mingyue, Dehai Li, Xue Xia, et al.. (2024). IL-27 disturbs lipid metabolism and restrains mitochondrial activity to inhibit γδ T17 cell-mediated skin inflammation. Cell Death and Disease. 15(7). 491–491. 5 indexed citations
9.
Hu, Yifan, Dawei Huang, Qian Yu, et al.. (2024). Decreased risk of COVID-19 and long COVID in patients with psoriasis receiving IL-23 inhibitor: A cross-sectional cohort study from China. Heliyon. 10(2). e24096–e24096. 6 indexed citations
10.
Liao, Chongshan, Jiajing Lu, Kar Yan Li, et al.. (2023). Improvement of parents’ oral health knowledge by a school-based oral health promotion for parents of preschool children: a prospective observational study. BMC Oral Health. 23(1). 890–890. 5 indexed citations
11.
Huang, Dawei, et al.. (2023). Development of bullous pemphigoid during treatment of psoriasis with ustekinumab: a case report and literature review. Frontiers in Medicine. 10. 1171802–1171802. 5 indexed citations
12.
13.
14.
Lu, Jiajing, Chunyuan Guo, Peng Chen, et al.. (2023). TLR7-MyD88-DC-CXCL16 axis results neutrophil activation to elicit inflammatory response in pustular psoriasis. Cell Death and Disease. 14(5). 315–315. 15 indexed citations
15.
16.
Li, Ying, Jiajing Lu, Yingyuan Yu, et al.. (2022). Drug Survival Outcomes Associated with the Real-World Use of Ixekizumab, Secukinumab, Guselkumab, and Adalimumab for the Treatment of Plaque Psoriasis in China: A 52-Week Single-Center Retrospective Study. Clinical Cosmetic and Investigational Dermatology. Volume 15. 2245–2252. 11 indexed citations
17.
Yu, Ning, Hui Qin, Yingyuan Yu, et al.. (2022). A Distinct Immature Low-Density Neutrophil Population Characterizes Acute Generalized Pustular Psoriasis. Journal of Investigative Dermatology. 142(10). 2831–2835.e5. 8 indexed citations
18.
Zhang, Xing, Jiajing Lu, Jing Dong, et al.. (2022). Glucose transporters: Important regulators of endometrial cancer therapy sensitivity. Frontiers in Oncology. 12. 933827–933827. 5 indexed citations
19.
Li, Ying, Yingyuan Yu, Yu Wang, et al.. (2022). Ixekizumab four-week dosing is comparable to two-week dosing in psoriasis patients and reduces treatment costs: experience in a real-world setting over a 12-week period. European Journal of Dermatology. 32(5). 618–622. 3 indexed citations
20.
Lu, Jiajing, John P. McMurtry, & C.N. Coon. (2007). Developmental Changes of Plasma Insulin, Glucagon, Insulin-like Growth Factors, Thyroid Hormones, and Glucose Concentrations in Chick Embryos and Hatched Chicks. Poultry Science. 86(4). 673–683. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gui Yang Breakdown of academic impact, for papers by Aouatef Ismail Chouchane Breakdown of academic impact, for papers by E. Schauer Breakdown of academic impact, for papers by Caterina Curato Breakdown of academic impact, for papers by Diána Simon Breakdown of academic impact, for papers by László Pàlinkàs Breakdown of academic impact, for papers by Katri Niemi Breakdown of academic impact, for papers by Yoon Sook Lee Breakdown of academic impact, for papers by Mylène Vivinus-Nébot Breakdown of academic impact, for papers by Shiyuan Huang
Rankless by CCL
2026